R. Cazares-Tamez's research while affiliated with Universidad de Monterrey and other places

Publication (1)

Article
Full-text available
Daratumumab (DARA) is a medication that in 2016 proved its efficacy and safety in the treatment of multiple myeloma. This product, based on a monoclonal antibody, technically generates an interference in most blood compatibility tests, artificially producing high blood pan-reactivity and incompatibility. The difficulty in finding blood compatible w...